The MedicX Fund Limited Notice of Dividend (3948W)
August 01 2018 - 2:01AM
UK Regulatory
TIDMMXF
RNS Number : 3948W
The MedicX Fund Limited
01 August 2018
Press Release
For immediate release
1 August 2018
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Notice of dividend
The Directors have approved a quarterly dividend of 1.51p per
Ordinary Share in respect of the period 1 April 2018 to 30 June
2018. The Directors expect, subject to unforeseen circumstances, to
pay dividends totalling 6.04p per Ordinary Share in respect of the
financial year ending 30 September 2018. The dividend will be paid
on 28 September 2018 to ordinary shareholders on the register as at
17 August 2018 (the "Record Date"). The corresponding ex-dividend
date will be 16 August 2018.
This quarterly dividend will comprise 50% (0.755p) Property
Income Distribution ("PID") and 50% ordinary dividend (0.755p). For
shareholders who qualify for gross payment of distributions, forms
to register for gross PIDs are available on the Company's website
at
http://www.medicxfund.com/investors/declaration-eligibility-pid-payments.
Eligibility declarations must be returned to the Company's
registrar, Link Asset Services, Corporate Actions, The Registry, 34
Beckenham Road, Beckenham, Kent, BR3 4TU to arrive by the Record
Date. Please click on the above link or refer to the Company's
website to obtain an eligibility declaration form.
The Company is offering qualifying shareholders the opportunity
to take new ordinary shares in the Company, credited as fully paid,
in lieu of the net cash dividend to be paid on 28 September 2018,
by participating in the Scrip Dividend Scheme (the "Scheme")
previously put in place by the Company on 5 May 2010. Following the
Company's notice of entry into the UK REIT regime effective from 1
October 2017, the Scrip Dividend Scheme Document was updated to
illustrate to shareholders the mechanics of the possibility of a
scrip alternative being offered for a dividend which is paid partly
or fully as a Property Income Distribution ("PID") as well as a
link to www.signalshares.com where shareholders can elect online to
receive their dividend in the form of new shares rather than
cash.
The option to participate will be available to shareholders
until 7 September 2018 (the "election date"). Further information
on the Scheme, together with a copy of the Scheme Document (which
contains the terms and conditions of the Scheme) and relevant
mandate form document, is available for inspection at the National
Storage Mechanism (http://www.morningstar.co.uk/uk/nsm), or through
the Scrip Dividend portal on the Company's website
(http://www.medicxfund.com/scrip).
End
For further information please contact:
Octopus Healthcare Adviser Ltd +44 (0) 345 0404 5555
Octopus Healthcare +44 (0) 20 3142 4820
Mike Adams, Executive Chairman
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Henry Wilson
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the
"Company", or together with its subsidiaries, the "Group") is the
specialist primary care infrastructure investor in modern,
purpose-built primary healthcare properties in the United Kingdom
and Ireland, listed on the London Stock Exchange, with a portfolio
comprising 166 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1.4 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP8.0 billion of funds for more than 50,000 retail and
institutional investors as well as supplying energy to more than
220,000 customers.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DIVFMGFNMMGGRZZ
(END) Dow Jones Newswires
August 01, 2018 02:01 ET (06:01 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2023 to Apr 2024